Literature DB >> 3805517

Progression of hypertrophic cardiomyopathy into a hypokinetic left ventricle: higher incidence in patients with midventricular obstruction.

S Fighali, Z Krajcer, S Edelman, R D Leachman.   

Abstract

The development of segmental or generalized left ventricular hypokinesia is an unusual occurrence in patients with hypertrophic cardiomyopathy. To determine the incidence and possible pathophysiologic mechanisms responsible for this process, the serial clinical and laboratory data of 62 patients with the diagnosis of hypertrophic cardiomyopathy were analyzed. During a mean follow-up period of 8 years (range 2 to 21), 5 patients (Group A) developed left ventricular hypokinesia, whereas the remaining 57 patients (Group B) continued to exhibit the clinical and laboratory findings of hypertrophic cardiomyopathy. Three patients developed a dilated left ventricle with generalized hypokinesia; two other patients had segmental left ventricular wall motion abnormalities. None of these five patients who developed left ventricular hypokinesia had fixed coronary artery disease. The mean age, sex, mean duration of follow-up, presence of coronary myocardial bridges and angina pectoris, and an interventricular gradient were all similar in Groups A and B. Midventricular obliteration was seen in 4 (80%) of the 5 patients in Group A and in 4 (7%) of the 57 patients in Group B (p less than 0.001). Findings from this study reveal that segmental or generalized left ventricular hypokinesia can develop in patients with hypertrophic cardiomyopathy in the absence of fixed coronary artery disease. Such hypokinesia can occur after an acute myocardial infarction or it can develop gradually without clinical or electrocardiographic evidence of infarction. Patients with the mid-ventricular obliteration variant of hypertrophic cardiomyopathy are at a higher risk of developing segmental or diffuse left ventricular hypokinesia.

Entities:  

Mesh:

Year:  1987        PMID: 3805517     DOI: 10.1016/s0735-1097(87)80377-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  24 in total

Review 1.  Pacing for drug-refractory or drug-intolerant hypertrophic cardiomyopathy.

Authors:  Mohammed Qintar; Abdulrahman Morad; Hazem Alhawasli; Khaled Shorbaji; Belal Firwana; Adib Essali; Waleed Kadro
Journal:  Cochrane Database Syst Rev       Date:  2012-05-16

2.  Malignant familial hypertrophic cardiomyopathy in a family with a 453Arg-->Cys mutation in the beta-myosin heavy chain gene: coexistence of sudden death and end-stage heart failure.

Authors:  Y L Ko; J J Chen; T K Tang; J J Cheng; S Y Lin; Y C Liou; P Kuan; C W Wu; W P Lien; C C Liew
Journal:  Hum Genet       Date:  1996-05       Impact factor: 4.132

3.  Percutaneous myocardial ablation for left mid-ventricular obstructive hypertrophic cardiomyopathy.

Authors:  I Tengiz; E Ercan; U O Türk
Journal:  Int J Cardiovasc Imaging       Date:  2005-12-12       Impact factor: 2.357

4.  Evaluation of apical pouches in hypertrophic cardiomyopathy using cardiac MRI.

Authors:  Kalie Y Kebed; Raed I Al Adham; Kalkidan Bishu; J Wells Askew; Kyle W Klarich; Jae K Oh; Paul R Julsrud; Thomas A Foley; James F Glockner; Rick A Nishimura; Steve R Ommen; Nandan S Anavekar
Journal:  Int J Cardiovasc Imaging       Date:  2014-01-05       Impact factor: 2.357

5.  Exercise stress echocardiography in hypertrophic cardiomyopathy.

Authors:  Kengo Suzuki; Yoshihiro J Akashi
Journal:  J Echocardiogr       Date:  2017-05-13

Review 6.  Hypertrophic cardiomyopathy in 2013: Current speculations and future perspectives.

Authors:  Georgios K Efthimiadis; Efstathios D Pagourelias; Thomas Gossios; Thomas Zegkos
Journal:  World J Cardiol       Date:  2014-02-26

7.  Clinical sustained uniform ventricular tachycardia in hypertrophic cardiomyopathy: association with left ventricular apical aneurysm.

Authors:  F Alfonso; M P Frenneaux; W J McKenna
Journal:  Br Heart J       Date:  1989-02

8.  Myocardial beta adrenoceptors and left ventricular function in hypertrophic cardiomyopathy.

Authors:  L Choudhury; S Guzzetti; D C Lefroy; P Nihoyannopoulos; W J McKenna; C M Oakley; P G Camici
Journal:  Heart       Date:  1996-01       Impact factor: 5.994

Review 9.  Atrial Fibrillation in Hypertrophic Obstructive Cardiomyopathy - Antiarrhythmics, Ablation and More!

Authors:  Gangadhar Malasana; John D Day; T Jared Bunch
Journal:  J Atr Fibrillation       Date:  2009-10-01

10.  Hypertrophic cardiomyopathy with midventricular obstruction and apical aneurysm formation in a single family: case report.

Authors:  Georgios K Efthimiadis; Christodoulos Pliakos; Efstathios D Pagourelias; Despina G Parcharidou; Georgios Spanos; Stylianos Paraskevaidis; Ioannis H Styliadis; Georgios Parcharidis
Journal:  Cardiovasc Ultrasound       Date:  2009-06-16       Impact factor: 2.062

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.